Hyperactive mTOR in podocytes contributes to kidney disease, and genetic reduction of podocyte-specific mTOR complex 1 (mTORC1) in diabetic animals suppresses the development of diabetic nephropathy (Gödel et al, 2011; Inoki et al, 2011). Here, MTOR is linked to kidney disorder.